Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy i...
Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer
About this item
Full title
Author / Creator
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background The DYNAMIC trial investigated the use of circulating tumor DNA (ctDNA) to guide adjuvant treatment decisions in stage II colon cancer. Despite the DYNAMIC trial's assertion that a ctDNA-guided approach could minimize the use of adjuvant treatment without compromising recurrence-free survival (RFS), we raised concerns regarding the trial...
Alternative Titles
Full title
Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_346a85a3670c4f41a96e483068deb5ac
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_346a85a3670c4f41a96e483068deb5ac
Other Identifiers
ISSN
1741-7015
E-ISSN
1741-7015
DOI
10.1186/s12916-023-03037-9
